This volume also provides an up-to-date guide for treatment that explores not only traditional treatments, but newer investigational treatment options including surgical resection, liver transplantation, ablation radiofrequency, microwavepercutaneous ethanol or acetic acid injection, transarterial chemoembolization TACEintra-arterial radiation therapy, and systemic chemotherapy.
Heptocellular Carcinoma: Targeted Therapy will be of great value to all health care professionals and trainees worldwide who have an interest in the diagnosis and pancreatic cancer targeted therapy of HCC, including surgeons, medical oncologists, radiologists, radiation oncologists, and pathologists. Table of contents 1.
HCC in patients without cirrhosis or hepatitis Dr. Pathology considerations TBA 4.
Diagnosis of HCC: the role of imaging studies 5. Screening Programs in High-Risk Populations 6.
Treatment Overview: Assembling a multidisciplinary team and selection of appropriate treatment options Drs. McMasters and Dr.
Vauthey 7. Norihiro Kokudo, University of Tokyo 8.
On behalf of the EAPC and the organizing committees, we would like to invite participants from all over the world to meet in the beautiful city of Madrid in Inthis international conference, with a large participation from different countries, revealed many new data from numerous clinical trials, which will change the medical practice. Attendees claimed CME credits, downloaded a Certificate of Attendance, and provided feedback during the meeting. Another important conference in which many oncologists from Romania participated in was the ESMO annual Congress. Across disciplines and across cultures, The European Society for Medical Oncology ESMO bridges the gap between researchers, pancreatic cancer targeted therapy and patients, and unites all stakeholders focused on finding the most effective cancer treatment solutions available today.
Portal Vein Embolization prior to resection Dr. Liver Transplantation for HCC Resection and reconstruction of inferior vena cava and hepatic veins for advanced HCC Dr.
Clinical Trial for Patients with Pancreatic Cancer
Alan Hemming, University of Florida Radiofrequency ablation for HCC Dr. Ronnie Poon, University of Hong Kong Microwave ablation Drs.
Transarterial Chemoembolization TBA Robert Martin, University of Louisville